Clinical Trial Update: Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial update examining whether vaginal 17β-estradiol improves urinary storage symptoms in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Lower Urinary Tract Symptoms
• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• 17β-Estradiol (17β-estradiol)

Snippet

Sponsor: Mahidol University | Conditions: Lower Urinary Tract Symptoms, Female Genitourinary Disease | Phase 4 | Status: COMPLETED